BARD

BARD

BARD

BARD (Best African American Response to Asthma Drugs) was a clinical trial for children, adolescents, and adults of African ancestry with poorly controlled asthma. The goal of BARD was to find out which asthma treatment, at what dose, works best for self-identified Blacks. BARD was sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The BARD study has been completed.

Read BARD Results